Insmed reported $2.52B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acelrx Pharmaceuticals ACRX:US $ 0.04B 0.04B
Alimera Sciences ALIM:US $ 0.04B 0B
Biomarin Pharmaceutical BMRN:US $ 14.26B 1.96B
Cytokinetics CYTK:US $ 3.15B 0.68B
Dbv Technologies DBVT:US 0.18B 0.01B
Dynavax Technologies DVAX:US $ 1.35B 0.33B
Gilead Sciences GILD:US $ 74.66B 16.42B
Heron Therapeutics HRTX:US $ 0.58B 0.35B
Insmed INSM:US $ 2.8B 0.44B
Mirati Therapeutics MRTX:US $ 4.56B 3.54B
Novartis NVS:US 214.39B 0.43B
Ophthotech OPHT:US $ 1.95B 0.03B
Regeneron Pharmaceuticals REGN:US $ 75.81B 7.89B
Sarepta Therapeutics SRPT:US $ 6.81B 1.03B
Seattle Genetics SGEN:US $ 26.45B 1.82B
Ultragenyx Pharmaceutical RARE:US $ 5.04B 0.69B
Vertex Pharmaceuticals VRTX:US $ 66.69B 10.85B